14.06 USD
+0.32 (+2.33%)
14.06 USD
0 (0%)
INMD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. INMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. INMD is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make INMD a good candidate for value investing.
1. Profitability
1.1 Basic Checks
INMD had positive earnings in the past year.
INMD had a positive operating cash flow in the past year.
Each year in the past 5 years INMD has been profitable.
In the past 5 years INMD always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of INMD (20.39%) is better than 98.94% of its industry peers.
INMD has a better Return On Equity (22.93%) than 95.21% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.95%, INMD belongs to the top of the industry, outperforming 92.55% of the companies in the same industry.
INMD had an Average Return On Invested Capital over the past 3 years of 22.89%. This is significantly above the industry average of 8.71%.
The 3 year average ROIC (22.89%) for INMD is well above the current ROIC(11.95%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.39% | ||
| ROE | 22.93% | ||
| ROIC | 11.95% |
ROA(3y)23.69%
ROA(5y)26.18%
ROE(3y)26.67%
ROE(5y)29.84%
ROIC(3y)22.89%
ROIC(5y)25.97%
1.3 Margins
INMD has a Profit Margin of 41.10%. This is amongst the best in the industry. INMD outperforms 98.40% of its industry peers.
In the last couple of years the Profit Margin of INMD has grown nicely.
With an excellent Operating Margin value of 23.98%, INMD belongs to the best of the industry, outperforming 94.68% of the companies in the same industry.
In the last couple of years the Operating Margin of INMD has declined.
INMD has a better Gross Margin (78.82%) than 91.49% of its industry peers.
In the last couple of years the Gross Margin of INMD has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.98% | ||
| PM (TTM) | 41.1% | ||
| GM | 78.82% |
OM growth 3Y-15.26%
OM growth 5Y-5.64%
PM growth 3Y-0.16%
PM growth 5Y3.28%
GM growth 3Y-1.88%
GM growth 5Y-1.59%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), INMD is creating value.
Compared to 1 year ago, INMD has less shares outstanding
INMD has more shares outstanding than it did 5 years ago.
There is no outstanding debt for INMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.39
WACC8.61%
2.3 Liquidity
INMD has a Current Ratio of 9.75. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of INMD (9.75) is better than 93.09% of its industry peers.
INMD has a Quick Ratio of 8.71. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
INMD has a Quick ratio of 8.71. This is amongst the best in the industry. INMD outperforms 92.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.75 | ||
| Quick Ratio | 8.71 |
3. Growth
3.1 Past
INMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.67%.
The Earnings Per Share has been growing by 22.97% on average over the past years. This is a very strong growth
The Revenue for INMD has decreased by -13.98% in the past year. This is quite bad
Measured over the past years, INMD shows a very strong growth in Revenue. The Revenue has been growing by 20.35% on average per year.
EPS 1Y (TTM)-23.67%
EPS 3Y-4.52%
EPS 5Y22.97%
EPS Q2Q%-45.71%
Revenue 1Y (TTM)-13.98%
Revenue growth 3Y3.36%
Revenue growth 5Y20.35%
Sales Q2Q%-28.46%
3.2 Future
INMD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.66% yearly.
Based on estimates for the next years, INMD will show a small growth in Revenue. The Revenue will grow by 0.63% on average per year.
EPS Next Y-9.5%
EPS Next 2Y-1.61%
EPS Next 3Y1.66%
EPS Next 5YN/A
Revenue Next Year-8.12%
Revenue Next 2Y-1.77%
Revenue Next 3Y0.63%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 8.90 indicates a reasonable valuation of INMD.
94.68% of the companies in the same industry are more expensive than INMD, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of INMD to the average of the S&P500 Index (25.47), we can say INMD is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.16, the valuation of INMD can be described as reasonable.
Based on the Price/Forward Earnings ratio, INMD is valued cheaply inside the industry as 95.74% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 34.42. INMD is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.9 | ||
| Fwd PE | 8.16 |
4.2 Price Multiples
98.40% of the companies in the same industry are more expensive than INMD, based on the Enterprise Value to EBITDA ratio.
INMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INMD is cheaper than 96.28% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.36 | ||
| EV/EBITDA | 2.66 |
4.3 Compensation for Growth
INMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.39
EPS Next 2Y-1.61%
EPS Next 3Y1.66%
5. Dividend
5.1 Amount
No dividends for INMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
14.06
+0.32 (+2.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners58.73%
Inst Owner Change2.11%
Ins Owners10.65%
Ins Owner ChangeN/A
Market Cap888.73M
Revenue(TTM)364.49M
Net Income(TTM)149.81M
Analysts72.31
Price Target17.14 (21.91%)
Short Float %5.38%
Short Ratio4.19
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.86%
Min EPS beat(2)5.11%
Max EPS beat(2)10.61%
EPS beat(4)2
Avg EPS beat(4)-4.56%
Min EPS beat(4)-20.27%
Max EPS beat(4)10.61%
EPS beat(8)4
Avg EPS beat(8)-5.17%
EPS beat(12)7
Avg EPS beat(12)-1.22%
EPS beat(16)11
Avg EPS beat(16)1.65%
Revenue beat(2)1
Avg Revenue beat(2)0.26%
Min Revenue beat(2)-2.87%
Max Revenue beat(2)3.38%
Revenue beat(4)1
Avg Revenue beat(4)-2.96%
Min Revenue beat(4)-9.96%
Max Revenue beat(4)3.38%
Revenue beat(8)2
Avg Revenue beat(8)-5.49%
Revenue beat(12)5
Avg Revenue beat(12)-3.96%
Revenue beat(16)9
Avg Revenue beat(16)-1.5%
PT rev (1m)3.38%
PT rev (3m)3.38%
EPS NQ rev (1m)-8.49%
EPS NQ rev (3m)-8.77%
EPS NY rev (1m)0.32%
EPS NY rev (3m)0.36%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)-0.04%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.9 | ||
| Fwd PE | 8.16 | ||
| P/S | 2.44 | ||
| P/FCF | 9.36 | ||
| P/OCF | 9.3 | ||
| P/B | 1.36 | ||
| P/tB | 1.36 | ||
| EV/EBITDA | 2.66 |
EPS(TTM)1.58
EY11.24%
EPS(NY)1.72
Fwd EY12.25%
FCF(TTM)1.5
FCFY10.68%
OCF(TTM)1.51
OCFY10.75%
SpS5.77
BVpS10.34
TBVpS10.34
PEG (NY)N/A
PEG (5Y)0.39
Graham Number19.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.39% | ||
| ROE | 22.93% | ||
| ROCE | 13.12% | ||
| ROIC | 11.95% | ||
| ROICexc | 59.43% | ||
| ROICexgc | 59.43% | ||
| OM | 23.98% | ||
| PM (TTM) | 41.1% | ||
| GM | 78.82% | ||
| FCFM | 26.04% |
ROA(3y)23.69%
ROA(5y)26.18%
ROE(3y)26.67%
ROE(5y)29.84%
ROIC(3y)22.89%
ROIC(5y)25.97%
ROICexc(3y)532.49%
ROICexc(5y)5023.19%
ROICexgc(3y)532.49%
ROICexgc(5y)5023.19%
ROCE(3y)25.13%
ROCE(5y)28.51%
ROICexgc growth 3Y-60.68%
ROICexgc growth 5YN/A
ROICexc growth 3Y-60.68%
ROICexc growth 5YN/A
OM growth 3Y-15.26%
OM growth 5Y-5.64%
PM growth 3Y-0.16%
PM growth 5Y3.28%
GM growth 3Y-1.88%
GM growth 5Y-1.59%
F-Score5
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 86.64% | ||
| Cap/Sales | 0.18% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 108.41% | ||
| Profit Quality | 63.36% | ||
| Current Ratio | 9.75 | ||
| Quick Ratio | 8.71 | ||
| Altman-Z | N/A |
F-Score5
WACC8.61%
ROIC/WACC1.39
Cap/Depr(3y)144.54%
Cap/Depr(5y)147.73%
Cap/Sales(3y)0.22%
Cap/Sales(5y)0.23%
Profit Quality(3y)91.09%
Profit Quality(5y)96.73%
High Growth Momentum
Growth
EPS 1Y (TTM)-23.67%
EPS 3Y-4.52%
EPS 5Y22.97%
EPS Q2Q%-45.71%
EPS Next Y-9.5%
EPS Next 2Y-1.61%
EPS Next 3Y1.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.98%
Revenue growth 3Y3.36%
Revenue growth 5Y20.35%
Sales Q2Q%-28.46%
Revenue Next Year-8.12%
Revenue Next 2Y-1.77%
Revenue Next 3Y0.63%
Revenue Next 5YN/A
EBIT growth 1Y-35.42%
EBIT growth 3Y-12.42%
EBIT growth 5Y13.55%
EBIT Next Year-39.83%
EBIT Next 3Y-11.3%
EBIT Next 5YN/A
FCF growth 1Y-44.72%
FCF growth 3Y-8.8%
FCF growth 5Y16.5%
OCF growth 1Y-44.69%
OCF growth 3Y-8.8%
OCF growth 5Y16.36%
INMODE LTD / INMD FAQ
Can you provide the ChartMill fundamental rating for INMODE LTD?
ChartMill assigns a fundamental rating of 7 / 10 to INMD.
What is the valuation status for INMD stock?
ChartMill assigns a valuation rating of 8 / 10 to INMODE LTD (INMD). This can be considered as Undervalued.
How profitable is INMODE LTD (INMD) stock?
INMODE LTD (INMD) has a profitability rating of 9 / 10.
What are the PE and PB ratios of INMODE LTD (INMD) stock?
The Price/Earnings (PE) ratio for INMODE LTD (INMD) is 8.9 and the Price/Book (PB) ratio is 1.36.
What is the financial health of INMODE LTD (INMD) stock?
The financial health rating of INMODE LTD (INMD) is 8 / 10.